ClinicalTrials.gg
Drug

Raloxifene clinical trials

Also written Evista and LY139481.

studies test it
47
open now
2
in phase 3
11
first study started
1994

How each study uses raloxifene is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the raloxifene studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
9 Dec 1997 · EVISTA · NDA 020815 (FDA, Drugs@FDA)
European Union
5 Aug 1998 · Evista · EMEA/H/C/000184 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Raloxifene
36
Raloxifene Hydrochloride
6
Raloxifene HCL
3

Brand

Optruma
1

Development codes

LY139481
4
LY-156758
1

Other names

Evista
16
Keoxifene
1

Studies by the year they started

46 studies that test it; most in 1998 (4)

Studies that test raloxifene, by start year
YearStudies
19941
19984
19992
20002
20014
20023
20032
20042
20064
20071
20081
20092
20102
20113
20122
20151
20162
20172
20182
20201
20211
20251
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
1
Phase 2
11
Phase 3
11
Phase 4
19
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 12 · Other 35

Eli Lilly and Company (9) · The Alfred (3) · Fundació Sant Joan de Déu (2) · Mayo Clinic (2) · University of Wisconsin, Madison (2) · Massachusetts General Hospital (1) · Hospital de Clinicas de Porto Alegre (1) · Yonsei University (1)

Often tested with

Tested in the same studies.

Teriparatide (5) · Alendronate (2) · Cholecalciferol (2) · Bicalutamide (2) · Multimodality Therapy (1) · Exemestane (1) · Tamoxifen (1) · Goserelin (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses raloxifene is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 47

See all 47 studies that test raloxifene →

Given beside what is tested · 4 — raloxifene is usual care or a partner of the new treatment
As the comparator · 5 — what is tested is compared with raloxifene

Codes

What other systems call raloxifene · ClinicalTrials.gg INT008774

  • MeSH (NLM) D020849Raloxifene HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) YX9162EO3IRALOXIFENEConfirmed FDA, NLM, Wikidata
  • RxNorm 72143Confirmed FDA, Wikidata
  • Wikidata Q425223raloxifeneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1518RaloxifeneOne source FDA
  • DrugBank DB00481One source Wikidata

Also registered as raloxifene hydrochloride (UNII 4F86W47BR6 · RxNorm 166551).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.